Quantcast

Thank you for stopping by...
The requested article is posted below, but first a little about this site...
I have been contacted by reporters such as Steven Brill and Jane Akre, lawyers from four countries such as Michael Huttner of the US, Jacquelyn NG from DEACONS in Hong Kong, Charlie Euchner Case Writer & Project Editor Yale School of Management, a variety of whistleblowers including Scott Bartz, one of the convicted (which I cannot disclose publicly) and numerous victims. They are all using the information from the Johnson and Toxin site for their court cases and research projects asking me to do specific research in addition to what is on the site. In the case of Steven Brill - a new project regarding known defective hips and knees and pharmaceutical products based on my work without any credit or compensation to me. I have basically been told to get a real job by most since I get nothing from any of them and they use my work for financial gain. This is beyond bullshit. They are obviously incapable of doing their own research regarding Johnson & Johnson and the pharmaceutical industry in general.
 
The site has also been visited numerous times by the World unHealth disOrganization, US Centers for Disease unControl, Department of Defenseless, Department of inJustice and even the US Federal Reserve and so on. A literal alphabet soup of government organizations.
 
This site also is also regularly by offices of the DOW, JPMorgan, CitiGroup, The Bank of New York Mellon Corp, Lloyds Banking Group PLC, Cantor Fitzgerald & Co., as well as other major financial institutions.
 
This site has been visited by numerous educational facilities including Quinnipiac University, Universitaet Graz, Baruch College, University of North Carolina at Chapel Hill, Yale, Miami Dade College, Marymount Manhattan College, Loyola University, Punjabi University, Franciscan University, Arizona State University, University of Surrey London, Loughborough University, Louisiana State University, Hong Kong University of Science and Technology, Oregon State University University of California, just to name a few.
 
And, of course, visitors from Johnson & Johnson servers around the world, Bayer, Synthes, Merk and others.
 
The only reason I am unable to afford a place to live is because people like the disgustingly wealthy above take my work and give NO contributions or credit. I choose to spend over 100 hours a week doing the research, maintaining the site and all promotion of the horrors of Johnson & Johnson for the benefit of all consumers, doctors and patients. I don't ask much, but a contribution would be greatly appreciated.
Thank you,
Emily Patterson :o)
 
$.00   
 

Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013
Johnson & Johnson consumer goods sales continue to slide in 2013 due to boycotts, recalls and more carcinogens in baby care products.

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, boycott, recall, baby, products
Date Created/Edited: 2013, May 12
 




Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
 
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
 
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-first-quarter-results
 
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-second-quarter-results
 

2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-third-quarter-results
 
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-fourth-quarter-and-full-year-results
 
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
 
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)
 
Resources:
1. Elizabeth Lopatto (2013, May 3). J&J Recalls Some Children’s Tylenol in South Korea Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-05-03/j-j-recalls-some-children-s-tylenol-in-south-korea.html
 
2. Ganesh N (2013, April 25). FDA suspends J&J Licence New indian Express. Retrieved from http://www.newindianexpress.com/nation/FDA-suspends-JJ-Licence/2013/04/25/article1560077.ece
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2015 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries